Key statistics
As of last trade Sarepta Therapeutics Inc (AB3A:BRN) traded at 129.98, -10.58% below its 52-week high of 145.36, set on Jun 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 129.98 |
---|---|
High | 129.98 |
Low | 129.98 |
Bid | 128.17 |
Offer | 128.63 |
Previous close | 129.98 |
Average volume | -- |
---|---|
Shares outstanding | 95.52m |
Free float | 91.34m |
P/E (TTM) | 90.87 |
Market cap | 10.55bn USD |
EPS (TTM) | 1.22 USD |
Data delayed at least 15 minutes, as of Jul 26 2024.
More ▼
Press releases
- Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results
- Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress
- Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors
- Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year
- Sarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼